Levana Sani

Co-founder and CEO, Nalagenetics

Tatler Asia
For using genetics to tailor safe and effective medication regimes

For some, medical side effects can be worse than the disease. Pharmacogenetics analyses how individuals’ genes respond to medications, but it has never been widely applied—until now. After Levana Sani helped isolate a gene that rendered leprosy medication fatal for some, she co-founded Nalagenetics to continue her research. The company localises genetic testing, making inexpensive test kits and partnering with Singaporean and Indonesian hospitals to make recommendations and inform patients.

Impacted Industries


  • Healthcare & Sciences

  • Technology